Maxell (6810) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
20 Oct, 2026Executive summary
Nine-month sales fell 1.8% YoY to ¥95,587 million; operating profit rose 1.7% to ¥6,578 million, and results exceeded plan overall.
Energy and Life Solution growth was offset by weakness in Optics & Systems; the full-year forecast remains unchanged.
Financial highlights
Gross profit rose to ¥24,270 million from ¥22,735 million; SG&A increased to ¥17,692 million from ¥16,264 million.
Ordinary profit declined 6.8% to ¥7,124 million; profit attributable to owners of parent fell 2.5% to ¥5,544 million, and comprehensive income declined 1.7% to ¥7,578 million.
Nine-month EPS was ¥125.47 versus ¥124.04 a year earlier; average exchange rate was ¥153 per US dollar versus ¥143.
Yen depreciation supported sales and operating profit, while foreign-exchange gains and losses weighed on ordinary profit and net profit.
Outlook and guidance
FY March 2025 forecast remains unchanged: sales ¥126,000 million, operating profit ¥8,000 million, profit attributable to owners of parent ¥6,000 million and EPS ¥135.79.
Q4 sales and operating profit are expected to remain at Q3 levels, supported by primary batteries, coated separators, and health and beauty care products.
Portfolio reform is under consideration to improve profitability beyond FY March 2026; one-time expenses may affect FY March 2025 results.
Latest events from Maxell
- Flat Q1 sales, 57.4% higher operating profit and unchanged FY2024 guidance.6810
Q1 2024 - Automotive optics and licensing drove 1H profit growth; FY sales guidance was cut.6810
Q2 2024 - Nine-month profit rose on automotive optics and licensing despite lower sales; guidance held.6810
Q3 2024 - Profit rose despite lower sales; FY2025 pairs steady guidance with MEX26 investment.6810
Q4 2024 - Operating profit grew despite lower sales as 150°C battery technology advanced.6810
Q1 2025 - FY2025 sales guidance fell, but the ¥8bn operating profit target was maintained.6810
Q2 2025 - Operating profit rose 15.3%, while shutdown costs drove attributable profit down 45.8%.6810
Q4 2025 - Energy and Functional Materials growth offset weaker segments; FY2026 guidance remains unchanged.6810
Q1 2026 - Primary batteries and early licensing lifted H1 profit; semiconductor recovery remains delayed.6810
Q2 2026